AbFero Pharmaceuticals
David Devos is a Scientific Advisor at AbFero Pharmaceuticals. David is also a Professor of Medical Pharmacology, University of Lille, France. Dr. Devos’s main research interests are preclinical and clinical studies of disease-modifying strategies in
neurodegenerative diseases, particularly Parkinson’s disease.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AbFero Pharmaceuticals
AbFero Pharmaceuticals is a privately held clinical-stage pharmaceutical company dedicated to treating diseases of iron overload. Their therapeutic platform addresses transfusion-related iron overload (TIO) and iron accumulation associated with diseases of aging, such as age-related macular degeneration (AMD), and Parkinson’s disease.